Skip to main content
. Author manuscript; available in PMC: 2022 May 1.
Published in final edited form as: FASEB J. 2021 May;35(5):e21563. doi: 10.1096/fj.202002747R

TABLE 1.

scRNA-seq output for each dataset in this study

Sample name Estimate number of cells Total reads Means reads/cell Median gene/cell Median UMI counts/cell Total detected gene # Sequencing saturation
Estrus 6,573 331 M 50,403 2,786 7,278 21,649 61.2%
V24Am 4,221 54 M 12,766 1,476 2,790 19,113 35.3%
V24Is 1,709 77 M 45,055 2,037 4,928 18,709 60.9%
E24AM 2,106 62 M 29,280 2,186 5,194 18,655 48.8%
E24Is 1,758 59 M 33,503 1,724 3,797 18,432 64.6%
Human fallopian tube 7,318 360 M 49,200 1,333 3,921 24,508 74.2%
Antibody table
Peptide/protein target Name of antibody Manufacturer, catalog no., and/or name of individual providing the antibody Species raised in; monoclonal or polyclonal Dilution used RRID
ESR1 (for IHC analysis) Estrogen receptor alpha (1D5) Thermo Fisher Scientific Cat# MA5-13191 Mouse; monoclonal 1:200 AB_10986080
PGR (for IHC analysis) Progesterone receptor (SP2) Thermo Fisher Scientific Cat# MA5- 14505 Rabbit; monoclonal 1:400 AB_10980030
Ki67 (for IHC analysis) Purified mouse anti- Ki67 BD Pharminogen Cat #550609 Mouse; monoclonal 1:100 AB_393778